Literature DB >> 16422668

Crystal structure of a glycosylated Fab from an IgM cryoglobulin with properties of a natural proteolytic antibody.

Paul A Ramsland1, Simon S Terzyan, Gwendolyn Cloud, Christina R Bourne, William Farrugia, Gordon Tribbick, H Mario Geysen, Carolyn R Moomaw, Clive A Slaughter, Allen B Edmundson.   

Abstract

The 2.6 A (1 A=0.1 nm) resolution structure has been determined for the glycosylated Fab (fragment antigen binding) of an IgM (Yvo) obtained from a subject with Waldenström's macroglobulinaemia. Dynamic light scattering was used to estimate the gel point and monitor the formation of an ordered hydroscopic gel of Yvo IgM upon cooling. If a cryoglobulin forms gels in peripheral tissues and organs, the associated swelling and damage to microvasculature can result in considerable morbidity and mortality. The three-dimensional structure of the branched N-linked oligosaccharide associated with the CH1 domain (first constant domain of heavy chain) is reported. The carbohydrate may act to shield part of the lateral surface of the CH1 domain and crowd the junction between the CH1 and CH2 domains, thereby limiting the segmental flexibility of the Fab arms in intact Yvo IgM, especially at low temperatures. Recently, Yvo IgM was shown to have the properties of a naturally occurring proteolytic antibody [Paul, Karle, Planque, Taguchi, Salas, Nishiyama, Handy, Hunter, Edmundson and Hanson (2004) J. Biol. Chem. 279, 39611-39619; Planque, Bangale, Song, Karle, Taguchi, Poindexter, Bick, Edmundson, Nishiyama and Paul (2004) J. Biol Chem. 279, 14024-14032]. The Yvo protein displayed the ability to cleave, by a nucleophilic mechanism, the amide bonds of a variety of serine protease substrates and the gp120 coat protein of HIV. An atypical serine, arginine and glutamate motif is located in the middle of the Yvo antigen-binding site and displays an overall geometry that mimics the classical serine, histidine and aspartate catalytic triad of serine proteases. Our present findings indicate that pre-existing or natural antibodies can utilize at least one novel strategy for the cleavage of peptide bonds.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16422668      PMCID: PMC1462693          DOI: 10.1042/BJ20051739

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

Review 1.  Immunoglobulin cross-reactivity examined by library screening, crystallography and docking studies.

Authors:  P A Ramsland; E Yuriev; A B Edmundson
Journal:  Comb Chem High Throughput Screen       Date:  2001-08       Impact factor: 1.339

2.  Binding of synthetic peptides by a human monoclonal IgM with an unusual combining site structure.

Authors:  A B Edmundson; G Tribbick; S Plompen; H M Geysen; E Yuriev; P A Ramsland
Journal:  J Mol Recognit       Date:  2001 Jul-Aug       Impact factor: 2.137

3.  Antibodies have the intrinsic capacity to destroy antigens.

Authors:  A D Wentworth; L H Jones; P Wentworth; K D Janda; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

4.  An unusual human IgM antibody with a protruding HCDR3 and high avidity for its peptide ligands.

Authors:  P A Ramsland; L Shan; C R Moomaw; C A Slaughter; Z Fan; L W Guddat; A B Edmundson
Journal:  Mol Immunol       Date:  2000-04       Impact factor: 4.407

Review 5.  Antibodies as defensive enzymes.

Authors:  Sudhir Paul; Yasuhiro Nishiyama; Stephanie Planque; Sangeeta Karle; Hiroaki Taguchi; Carl Hanson; Marc E Weksler
Journal:  Springer Semin Immunopathol       Date:  2005-01-05

6.  DNA hydrolyzing autoantibodies.

Authors:  A M Shuster; G V Gololobov; O A Kvashuk; A E Bogomolova; I V Smirnov; A G Gabibov
Journal:  Science       Date:  1992-05-01       Impact factor: 47.728

Review 7.  Cryoimmunoglobulins.

Authors:  H M Grey; P F Kohler
Journal:  Semin Hematol       Date:  1973-04       Impact factor: 3.851

8.  Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction.

Authors:  A L Corper; M K Sohi; V R Bonagura; M Steinitz; R Jefferis; A Feinstein; D Beale; M J Taussig; B J Sutton
Journal:  Nat Struct Biol       Date:  1997-05

9.  The molecular mechanism of cryoprecipitation and cold agglutination of an IgM lambda Waldenström macroglobulin with anti-Gd specificity: sedimentation analysis and localization of interacting sites.

Authors:  R J Weber; L W Clem
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

10.  Diverse binding site structures revealed in homology models of polyreactive immunoglobulins.

Authors:  P A Ramsland; L W Guddat; A B Edmundson; R L Raison
Journal:  J Comput Aided Mol Des       Date:  1997-09       Impact factor: 3.686

View more
  14 in total

1.  Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection.

Authors:  Eric L Brown; Yasuhiro Nishiyama; Jesse W Dunkle; Shreya Aggarwal; Stephanie Planque; Kenji Watanabe; Keri Csencsits-Smith; M Gabriela Bowden; Sheldon L Kaplan; Sudhir Paul
Journal:  J Biol Chem       Date:  2012-02-02       Impact factor: 5.157

2.  Antigen-specific proteolysis by hybrid antibodies containing promiscuous proteolytic light chains paired with an antigen-binding heavy chain.

Authors:  Gopal Sapparapu; Stephanie A Planque; Yasuhiro Nishiyama; Steven K Foung; Sudhir Paul
Journal:  J Biol Chem       Date:  2009-06-19       Impact factor: 5.157

3.  Constant domain-regulated antibody catalysis.

Authors:  Gopal Sapparapu; Stephanie Planque; Yukie Mitsuda; Gary McLean; Yasuhiro Nishiyama; Sudhir Paul
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

Review 4.  Beneficial catalytic immunity to abeta peptide.

Authors:  Sudhir Paul; Stephanie Planque; Yasuhiro Nishiyama
Journal:  Rejuvenation Res       Date:  2010 Apr-Jun       Impact factor: 4.663

5.  Naturally occurring catalytic antibodies: evidence for preferred development of the catalytic function in IgA class antibodies.

Authors:  Yukie Mitsuda; Stephanie Planque; Mariko Hara; Robert Kyle; Hiroaki Taguchi; Yasuhiro Nishiyama; Sudhir Paul
Journal:  Mol Biotechnol       Date:  2007-06       Impact factor: 2.695

6.  Covalent inactivation of factor VIII antibodies from hemophilia A patients by an electrophilic FVIII Analog.

Authors:  Stephanie Planque; Miguel A Escobar; Keri C Smith; Hiroaki Taguchi; Yasuhiro Nishiyama; Elizabeth Donnachie; Kathleen P Pratt; Sudhir Paul
Journal:  J Biol Chem       Date:  2008-03-11       Impact factor: 5.157

Review 7.  Catalytic antibodies to amyloid beta peptide in defense against Alzheimer disease.

Authors:  Hiroaki Taguchi; Stephanie Planque; Yasuhiro Nishiyama; Paul Szabo; Marc E Weksler; Robert P Friedland; Sudhir Paul
Journal:  Autoimmun Rev       Date:  2008-04-09       Impact factor: 9.754

8.  Exceptional amyloid beta peptide hydrolyzing activity of nonphysiological immunoglobulin variable domain scaffolds.

Authors:  Hiroaki Taguchi; Stephanie Planque; Gopal Sapparapu; Stephane Boivin; Mariko Hara; Yasuhiro Nishiyama; Sudhir Paul
Journal:  J Biol Chem       Date:  2008-10-30       Impact factor: 5.157

9.  Catalytic immunoglobulin gene delivery in a mouse model of Alzheimer's disease: prophylactic and therapeutic applications.

Authors:  Jinghong Kou; Junling Yang; Jeong-Eun Lim; Abhinandan Pattanayak; Min Song; Stephanie Planque; Sudhir Paul; Ken-Ichiro Fukuchi
Journal:  Mol Neurobiol       Date:  2014-04-15       Impact factor: 5.590

10.  A possible role for metallic ions in the carbohydrate cluster recognition displayed by a Lewis Y specific antibody.

Authors:  William Farrugia; Andrew M Scott; Paul A Ramsland
Journal:  PLoS One       Date:  2009-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.